Non-coding RNAs: Functions and applications in endocrine-related cancer

Molecular and Cellular Endocrinology

Volumn 416, Issue , 2015, Pages 88-96

  Venkatesh, Thejaswini ^a   Suresh, Padmanaban S ^b   Tsutsumi, Rie ^c  

^a NITTE UNIVERSITY   (India)

^b MANGALORE UNIVERSITY   (India)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Endocrine related cancer; Long non coding RNA; Non coding RNA; PIWI interacting RNA; Small nucleolar RNA; TRNA derived small RNA; Y RNA

Indexed keywords

TRANSFER RNA; UNTRANSLATED RNA; LONG UNTRANSLATED RNA; SMALL INTERFERING RNA; SMALL NUCLEOLAR RNA; TRANSCRIPTOME; TUMOR MARKER;

BREAST CANCER; CARCINOGENESIS; CELL PROLIFERATION; DISEASE ASSOCIATION; DOWN REGULATION; ENDOCRINE TUMOR; ENDOMETRIUM CANCER; EPIGENETICS; GENE CONTROL; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN DENATURATION; PROTEIN FUNCTION; PROTEIN PROCESSING; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SEQUENCE ALIGNMENT; SURVIVAL RATE; TESTIS CANCER; TRANSCRIPTION REGULATION; UPREGULATION; CLASSIFICATION; ENDOCRINE GLAND NEOPLASMS; FEMALE; GENETICS; MALE; METABOLISM;

BIOMARKERS, TUMOR; ENDOCRINE GLAND NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; RNA, LONG NONCODING; RNA, SMALL INTERFERING; RNA, SMALL NUCLEOLAR; TRANSCRIPTOME;

EID: 84943663013     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2015.08.026     Document Type: Review

References (94)

1. Anderson P., Ivanov P. tRNA fragments in human health and disease. FEBS Lett. 2014, 588:4297-4304.
2. Askarian-Amiri M.E., Crawford J., French J.D., Smart C.E., Smith M.A., Clark M.B., Ru K., Mercer T.R., Thompson E.R., Lakhani S.R., Vargas A.C., Campbell I.G., Brown M.A., Dinger M.E., Mattick J.S. SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer. RNA 2011, 17:878-891.
3. Bamezai S., Rawat V.P., Buske C. Concise review: the Piwi-piRNA axis: pivotal beyond transposon silencing. Stem Cells 2012, 30:2603-2611.
4. Berteaux N., Lottin S., Monté D., Pinte S., Quatannens B., Coll J., Hondermarck H., Curgy J.J., Dugimont T., Adriaenssens E. H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1. J. Biol. Chem. 2005, 280:29625-29636.
5. Blenkiron C., Hurley D.G., Fitzgerald S., Print C.G., Lasham A. Links between the oncoprotein YB-1 and small non-coding RNAs in breast cancer. PLoS One 2013, 8.
6. Borek E., Baliga B.S., Gehrke C.W., Kuo C.W., Belman S., Troll W., Waalkes T.P. High turnover rate of transfer RNA in tumor tissue. Cancer Res. 1977, 37:3362-3366.
7. Brunner A.L., Beck A.H., Edris B., Sweeney R.T., Zhu S.X., Li R., Montgomery K., Varma S., Gilks T., Guo X., Foley J.W., Witten D.M., Giacomini C.P., Flynn R.A., Pollack J.R., Tibshirani R., Chang H.Y., van de Rijn M., West R.B. Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancers. Genome Biol. 2012, 13:R75.
8. Carmell M.A., Xuan Z., Zhang M.Q., Hannon G.J. The Argonaute family: tentacles that reach into RNAi, developmental control, stem cell maintenance, and tumorigenesis. Genes Dev. 2002, 16:2733-2742.
9. Cheng J., Deng H., Xiao B., Zhou H., Zhou F., Shen Z., Guo J. piR-823, a novel non-coding small RNA, demonstrates in vitro and in vivo tumor suppressive activity in human gastric cancer cells. Cancer Lett. 2012, 315:12-17.
10. Cheng J., Guo J.M., Xiao B.X., Miao Y., Jiang Z., Zhou H., Li Q.N. PiRNA, the new non-coding RNA, is aberrantly expressed in human cancer cells. Clin. Chim. Acta 2011, 412:1621-1625.
11. Christov C.P., Gardiner T.J., Szuts D., Krude T. Functional requirement of noncoding Y RNAs for human chromosomal DNA replication. Mol. Cell. Biol. 2006, 26:6993-7004.
12. Christov C.P., Trivier E., Krude T. Noncoding human Y RNAs are overexpressed in tumours and required for cell proliferation. Br. J. Cancer 2008, 98:981-988.
13. Crea F., Clermont P.L., Parolia A., Wang Y., Helgason C.D. The non-coding transcriptome as a dynamic regulator of cancer metastasis. Cancer Metastasis Rev. 2014, 33:1-16.
14. Derrien T., Johnson R., Bussotti G., Tanzer A., Djebali S., Tilgner H., Guernec G., Martin D., Merkel A., Knowles D.G., Lagarde J., Veeravalli L., Ruan X., Ruan Y., Lassmann T., Carninci P., Brown J.B., Lipovich L., Gonzalez J.M., Thomas M., Davis C.A., Shiekhattar R., Gingeras T.R., Hubbard T.J., Notredame C., Harrow J., Guigo R. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012, 22:1775-1789.
15. Dhahbi J.M., Spindler S.R., Atamna H., Boffelli D., Martin D.I. Deep sequencing of serum small RNAs identifies patterns of 5' tRNA half and YRNA fragment expression associated with breast cancer. Biomark. Cancer 2014, 6:37-47.
16. Dhahbi J.M. 5' tRNA halves: the next generation of immune signaling molecules. Front. Immunol. 2015, 6:74.
17. Diehl J.A. Cycling to cancer with cyclin D1. Cancer Biol. Ther. 2002, 1:226-231.
18. Djebali S., Davis C.A., Merkel A., Dobin A., Lassmann T., Mortazavi A., Tanzer A., Lagarde J., Lin W., Schlesinger F., Xue C., Marinov G.K., Khatun J., Williams B.A., Zaleski C., Rozowsky J., Röder M., Kokocinski F., Abdelhamid R.F., Alioto T., Antoshechkin I., Baer M.T., Bar N.S., Batut P., Bell K., Bell I., Chakrabortty S., Chen X., Chrast J., Curado J., Derrien T., Drenkow J., Dumais E., Dumais J., Duttagupta R., Falconnet E., Fastuca M., Fejes-Toth K., Ferreira P., Foissac S., Fullwood M.J., Gao H., Gonzalez D., Gordon A., Gunawardena H., Howald C., Jha S., Johnson R., Kapranov P., King B., Kingswood C., Luo O.J., Park E., Persaud K., Preall J.B., Ribeca P., Risk B., Robyr D., Sammeth M., Schaffer L., See L.-H., Shahab A., Skancke J., Suzuki A.M., Takahashi H., Tilgner H., Trout D., Walters N., Wang H., Wrobel J., Yu Y., Ruan X., Hayashizaki Y., Harrow J., Gerstein M., Hubbard T., Reymond A., Antonarakis S.E., Hannon G., Giddings M.C., Ruan Y., Wold B., Carninci P., Guigó R., Gingeras T.R. Landscape of transcription in human cells. Nature 2012, 489:100-108.
19. Dong X.Y., Guo P., Boyd J., Sun X., Li Q., Zhou W., Dong J.T. Implication of snoRNA U50 in human breast cancer. J. Genet. Genom. 2009, 36:447-454.
20. Dong X.Y., Rodriguez C., Guo P., Sun X., Talbit J.T., Zhou W., Petros J., Li Q., Vessella L., Kibel A.S., Stevens V.L., Calle E.E., Dong J.T. SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer. Hum. Mol. Genet. 2008, 17:1031-1042.
21. Ender C., Krek A., Friedländer M.R., Beitzinger M., Weinmann L., Chen W., Pfeffer S., Rajewsky N., Meister G. A human snoRNA with MicroRNA-like functions. Mol. Cell 2008, 32:519-528.
22. Esposito T., Magliocca S., Formicola D., Gianfrancesco F. piR_015520 belongs to Piwi-associated RNAs regulates expression of the human melatonin receptor 1A gene. PLoS One 2011, 6:e22727.
23. Esteller M. Non-coding RNAs in human disease. Nat. Rev. Genet. 2011, 12:861-874.
24. Ferreira H.J., Heyn H., del Muro X.G., Vidal A., Larriba S., Muñoz C., Villanueva A., Esteller M. Epigenetic loss of the piwi/pirna machinery in human testicular tumorigenesis. Epigenetics 2014, 9:113-118.
25. Garcia-Silva M.R., Cabrera-Cabrera F., Güida M.C., Cayota A. Hints of tRNA-derived small RNAs role in RNA silencing mechanisms. Genes (Basel) 2012, 3:603-614.
26. Gee H.E., Buffa F.M., Camps C., Ramachandran A., Leek R., Taylor M., Patil M., Sheldon H., Betts G., Homer J., West C., Ragoussis J., Harris A.L. The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis. Br. J. Cancer 2011, 104:1168-1177.
27. Gendron M., Roberge D., Boire G. Heterogeneity of human Ro ribonucleoproteins (RNPS): nuclear retention of Ro RNPS containing the human hY5 RNA in human and mouse cells. Clin. Exp. Immunol. 2001, 125:162-168.
28. Gibb E.A., Brown C.J., Lam W.L. The functional role of long non-coding RNA in human carcinomas. Mol. Cancer 2011, 10:38.
29. Goodarzi H., Liu X., Nguyen H.C., Zhang S., Fish L., Tavazoie S.F. Endogenous tRNA-derived fragments suppress breast cancer progression via YBX1 displacement. Cell 2015, 161:790-802.
30. Gupta R.A., Shah N., Wang K.C., Kim J., Horlings H.M., Wong D.J., Tsai M.-C., Hung T., Argani P., Rinn J.L., Wang Y., Brzoska P., Kong B., Li R., West R.B., van de Vijver M.J., Sukumar S., Chang H.Y. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010, 464:1071-1076.
31. Guzman N., Agarwal K., Asthagiri D., Saji M., Ringel M.D., Paulaitis M.E. Breast cancer-specific miR signature unique to extracellular vesicles includes "microRNA-like" tRNA fragments. Mol. Cancer Res. 2015, 13:891-901.
32. He Y., Vogelstein B., Velculescu V.E., Papadopoulos N., Kinzler K.W. The antisense transcriptomes of human cells. Science 2008, 322:1855-1857.
33. Huang G., Hu H., Xue X., Shen S., Gao E., Guo G., Shen X., Zhang X. Altered expression of piRNAs and their relation with clinicopathologic features of breast cancer. Clin. Transl. Oncol. 2013, 15:563-568.
34. Huang X., Yin H., Sweeney S., Raha D., Snyder M., Lin H. A major epigenetic programming mechanism guided by piRNAs. Dev. Cell 2013, 24:502-516.
35. Iyer M.K., Niknafs Y.S., Malik R., Singhal U., Sahu A., Hosono Y., Barrette T.R., Prensner J.R., Evans J.R., Zhao S., et al. The landscape of long noncoding RNAs in the human transcriptome. Nat. Genet. 2015, 47:199-208.
36. Jochl C., Rederstorff M., Hertel J., Stadler P.F., Hofacker I.L., Schrettl M., Haas H., Huttenhofer A. Small ncRNA transcriptome analysis from Aspergillus fumigatus suggests a novel mechanism for regulation of protein synthesis. Nucleic Acids Res. 2008, 36:2677-2689.
37. Kawaji H., Hayashizaki Y. Exploration of small RNAs. PLoS Genet. 2008, 4:e22.
38. Kentwell J., Gundara J.S., Sidhu S.B. Noncoding RNAs in endocrine malignancy. Oncologist 2014, 19:483-491.
39. Kim T.-K., Hemberg M., Gray J.M., Costa A.M., Bear D.M., Wu J., Harmin D.A., Laptewicz M., Barbara-Haley K., Kuersten S., Markenscoff-Papadimitriou E., Kuhl D., Bito H., Worley P.F., Kreiman G., Greenberg M.E. Widespread transcription at neuronal activity-regulated enhancers. Nature 2010, 465:182-187.
40. Kim V.N., Han J., Siomi M.C. Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol. 2009, 10:126-139.
41. Kodahl A.R., Lyng M.B., Binder H., Cold S., Gravgaard K., Knoop A.S., Ditzel H.J. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study. Mol. Oncol. 2014, 8:874-883.
42. Kwon C., Tak H., Rho M., Chang H.R., Kim Y.H., Kim K.T., Balch C., Lee E.K., Nam S. Detection of PIWI and piRNAs in the mitochondria of mammalian cancer cells. Biochem. Biophys. Res. Commun. 2014, 446:218-223.
43. Lee J.H., Schutte D., Wulf G., Fuzesi L., Radzun H.J., Schweyer S., Engel W., Nayernia K. Stem-cell protein Piwil2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-XL pathway. Hum. Mol. Genet. 2006, 15:201-211.
44. Lee Y.S., Shibata Y., Malhotra A., Dutta A. A novel class of small RNAs: tRNA-derived RNA fragments (tRFs). Genes Dev. 2009, 23:2639-2649.
45. Lennox K.A., Owczarzy R., Thomas D.M., Walder J.A., Behlke M.A. Improved performance of anti-miRNA oligonucleotides using a novel non-nucleotide modifier. Mol. Ther. Nucleic Acids 2013, 2:e117.
46. Lerner M.R., Boyle J.A., Hardin J.A., Steitz J.A. Two novel classes of small ribonucleoproteins detected by antibodies associated with lupus erythematosus. Science 1981, 211:400-402.
47. Li D., Sun X., Yan D., Huang J., Luo Q., Tang H., Peng Z. Piwil2 modulates the proliferation and metastasis of colon cancer via regulation of matrix metallopeptidase 9 transcriptional activity. Exp. Biol. Med. (Maywood) 2012, 237:1231-1240.
48. Lim S.L., Ricciardelli C., Oehler M.K., Tan I.M., Russell D., Grutzner F. Overexpression of piRNA pathway genes in epithelial ovarian cancer. PLoS One 2014, 9:e99687.
49. Liu W.K., Jiang X.Y., Zhang Z.X. Expression of PSCA, PIWIL1 and TBX2 and its correlation with HPV16 infection in formalin-fixed, paraffin-embedded cervical squamous cell carcinoma specimens. Arch. Virol. 2010, 155:657-663.
50. Liu J.J., Shen R., Chen L., Ye Y., He G., Hua K., Jarjoura D., Nakano T., Ramesh G.K., Shapiro C.L., et al. Piwil2 is expressed in various stages of breast cancers and has the potential to be used as a novel biomarker. Int. J. Clin. Exp. Pathol. 2010, 3:328-337.
51. Lu Y., Zhang K., Li C., Yao Y., Tao D., Liu Y., Zhang S., Ma Y. Piwil2 suppresses p53 by inducing phosphorylation of signal transducer and activator of transcription 3 in tumor cells. PLoS One 2012, 7:e30999.
52. Mani S.R., Juliano C.E. Untangling the web: the diverse functions of the PIWI/piRNA pathway. Mol. Reprod. Dev. 2013, 80:632-664.
53. Mannoor K., Liao J., Jiang F. Small nucleolar RNAs in cancer. Biochim. Biophys. Acta Rev. Cancer 2012, 1826:1.
54. Matouk I.J., DeGroot N., Mezan S., Ayesh S., Abu-lail R., Hochberg A., Galun E. The H19 non-coding RNA is essential for human tumor growth. PLoS One 2007, 2:e845.
55. Mattick J.S. Non-coding RNAs: the architects of eukaryotic complexity. EMBO Rep. 2001, 2:986-991.
56. Maute R.L., Schneider C., Sumazin P., Holmes A., Califano A., Basso K., Dalla-Favera R. tRNA-derived microRNA modulates proliferation and the DNA damage response and is down-regulated in B cell lymphoma. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:1404-1409.
57. Mei Y., Clark D., Mao L. Novel dimensions of piRNAs in cancer. Cancer Lett. 2013, 336:46-52.
58. Mei Y.-P., Liao J.-P., Shen J., Yu L., Liu B.-L., Liu L., Li R.-Y., Ji L., Dorsey S.G., Jiang Z.-R., Katz R.L., Wang J.-Y., Jiang F. Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis. Oncogene 2012, 31:2794-2804.
59. Morrish T.A., Gilbert N., Myers J.S., Vincent B.J., Stamato T.D., Taccioli G.E., Batzer M.A., Moran J.V. DNA repair mediated by endonuclease-independent LINE-1 retrotransposition. Nat. Genet. 2002, 31:159-165.
60. Mourtada-Maarabouni M., Pickard M.R., Hedge V.L., Farzaneh F., Williams G.T. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene 2009, 28:195-208.
61. Nakamura E., Kozaki K.I., Tsuda H., Suzuki E., Pimkhaokham A., Yamamoto G., Irie T., Tachikawa T., Amagasa T., Inazawa J., Imoto I. Frequent silencing of a putative tumor suppressor gene melatonin receptor 1 A (MTNR1A) in oral squamous-cell carcinoma. Cancer Sci. 2008, 99:1390-1400.
62. Nallar S.C., Kalvakolanu D.V. Regulation of snoRNAs in cancer: close encounters with interferon. J. Interferon Cytokine Res. 2013, 33:189-198.
63. Olson K.A., Fett J.W., French T.C., Key M.E., Vallee B.L. Angiogenin antagonists prevent tumor growth in vivo. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:442-446.
64. Pickard M.R., Mourtada-Maarabouni M., Williams G.T. Long non-coding RNA GAS5 regulates apoptosis in prostate cancer cell lines. Biochim. Biophys. Acta 2013, 1832:1613-1623.
65. Prensner J.R., Chinnaiyan A.M. The emergence of lncRNAs in cancer biology. Cancer Discov. 2011, 1:391-407.
66. Prensner J.R., Chinnaiyan A.M. Oncogenic gene fusions in epithelial carcinomas. Curr. Opin. Genet. Dev. 2009, 19:82-91.
67. Qi P., Du X. The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod. Pathol. 2013, 26:155-165.
68. Qiao D., Zeeman A.-M., Deng W., Looijenga L.H.J., Lin H. Molecular characterization of hiwi, a human member of the piwi gene family whose overexpression is correlated to seminomas. Oncogene 2002, 21:3988-3999.
69. Qiu J.J., Lin Y.Y., Ding J.X., Feng W.W., Jin H.Y., Hua K.Q. Long non-coding RNA ANRIL predicts poor prognosis and promotes invasion/metastasis in serous ovarian cancer. Int. J. Oncol. 2015, 46:2497-2505.
70. Ravo M., Cordella A., Rinaldi A., Bruno G., Alexandrova E., Saggese P., Nassa G., Giurato G., Tarallo R., Marchese G., et al. Small non-coding RNA deregulation in endometrial carcinogenesis. Oncotarget 2015, 6:4677-4691.
71. Ren A., Dong Y., Tsoi H., Yu J. Detection of miRNA as non-invasive biomarkers of colorectal cancer. Int. J. Mol. Sci. 2015, 16:2810-2823.
72. Richard P., Kiss T. Integrating snoRNP assembly with mRNA biogenesis. EMBO Rep. 2006, 7:590-592.
73. Sapre N., Selth L.A. Circulating microRNAs as biomarkers of prostate cancer: the state of play. Prostate Cancer 2013, 2013:539680.
74. Shibata C., Otsuka M., Kishikawa T., Ohno M., Yoshikawa T., Takata A., Koike K. Diagnostic and therapeutic application of noncoding RNAs for hepatocellular carcinoma. World J. Hepatol. 2015, 7:1-6.
75. Speer J., Gehrke C.W., Kuo K.C., Waalkes T.P., Borek E. tRNA breakdown products as markers for cancer. Cancer 1979, 44:2120-2133.
76. Su H., Xu T., Ganapathy S., Shadfan M., Long M., Huang T.H.-M., Thompson I., Yuan Z.-M. Elevated snoRNA biogenesis is essential in breast cancer. Oncogene 2014, 33:1348-1358.
77. Suzuki R., Honda S., Kirino Y. PIWI expression and function in Cancer. Front. Genet. 2012, 3:204.
78. Tan A.S., Baty J.W., Dong L.F., Bezawork-Geleta A., Endaya B., Goodwin J., Bajzikova M., Kovarova J., Peterka M., Yan B., et al. Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA. Cell Metab. 2015, 21:81-94.
79. Thomson D.W., Bracken C.P., Goodall G.J. Experimental strategies for microRNA target identification. Nucleic Acids Res. 2011, 39:6845-6853.
80. Thompson D.M., Lu C., Green P.J., Parker R. tRNA cleavage is a conserved response to oxidative stress in eukaryotes. RNA 2008, 14:2095-2103.
81. Thompson D.M., Parker R. Stressing out over tRNA cleavage. Cell 2009, 138:215-219.
82. Tomlins S.A., Laxman B., Dhanasekaran S.M., Helgeson B.E., Cao X., Morris D.S., Menon A., Jing X., Cao Q., Han B., Yu J., Wang L., Montie J.E., Rubin M.A., Pienta K.J., Roulston D., Shah R.B., Varambally S., Mehra R., Chinnaiyan A.M. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 2007, 448:595-599.
83. Tripathi V., Ellis J.D., Shen Z., Song D.Y., Pan Q., Watt A.T., Freier S.M., Bennett C.F., Sharma A., Bubulya P.A., Blencowe B.J., Prasanth S.G., Prasanth K.V. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol. Cell 2010, 39:925-938.
84. Tsang W.P., Ng E.K.O., Ng S.S.M., Jin H., Yu J., Sung J.J.Y., Kwok T.T. Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis 2010, 31:350-358.
85. Wang D., Garcia-Bassets I., Benner C., Li W., Su X., Zhou Y., Qiu J., Liu W., Kaikkonen M.U., Ohgi K.A., Glass C.K., Rosenfeld M.G., Fu X.-D. Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA. Nature 2011, 474:390-394.
86. Wang F., Ren S., Chen R., Lu, Shi, Zhu, Zhang, Jing, Zhang, Shen J., et al. Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancer. Oncotarget 2014, 5:11091-11102.
87. Wang Q., Lee I., Ren J., Ajay S.S., Lee Y.S., Bao X. Identification and functional characterization of tRNA-derived RNA fragments (tRFs) in respiratory syncytial virus infection. Mol. Ther. 2013, 21:368-379.
88. Wang X., Arai S., Song X., Reichart D., Du K., Pascual G., Tempst P., Rosenfeld M.G., Glass C.K., Kurokawa R. Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature 2008, 454:126-130.
89. Weick E.M., Miska E.A. piRNAs: from Biogenesis to Function Development 2014, vol. 141:3458-3471.
90. Williams G.T., Farzaneh F. Are snoRNAs and snoRNA host genes new players in cancer?. Nat. Rev. Cancer 2012, 12:84-88.
91. Yang W.-H., Bloch D.B. Probing the mRNA processing body using protein macroarrays and "autoantigenomics". RNA 2007, 13:704-712.
92. Yap K.L., Li S., Munoz-Cabello A.M., Raguz S., Zeng L., Mujtaba S., Gil J., Walsh M.J., Zhou M.M. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 Lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol. Cell 2010, 38:662-674.
93. Yoon J.H., Abdelmohsen K., Srikantan S., Yang X., Martindale J.L., De S., Huarte M., Zhan M., Becker K.G., Gorospe M. LincRNA-p21 suppresses target mRNA translation. Mol. Cell 2012, 47:648-655.
94. Zhang H., Ren Y., Xu H., Pang D., Duan C., Liu C. The expression of stem cell protein Piwil2 and piR-932 in breast cancer. Surg. Oncol. 2013, 22:217-223.